相关实验视频
Updated: Jun 30, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
在儿科急性淋巴细胞白血病中基于生理学的药物动力学建模的概念验证
1Department of Clinical Pharmacy, Institute for Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
基于生理学上的药理动力学 (PBPK) 建模准确地描述了儿科白血病患者的L-阿斯巴拉金酶药理动力学. 这种全身PBPK模型为人群药动力学建模提供了有价值的替代方案,特别是在小型患者群体中.
科学领域:
- 药理动力学 药理动力学
- 制药指标 (Pharmacometrics) 是一个指标.
- 生物医学建模模型
背景情况:
- 基于生理学的药理动力学 (PBPK) 建模是药理动力学的新兴技术.
- PBPK建模补充了人群的药理动力学,特别是在小患者群体中.
研究的目的:
- 为了建立应用全身PBPK建模来描述L-亚斯巴拉金酶的药理动力学的概念证明.
- 评估PBPK模型在患有急性淋巴细胞白血病的儿科患者中的准确性和预测性能.
主要方法:
- 使用了来自两个随机,双盲,II/III期临床研究 (MC-ASP.4/ALL;MC-ASP.5/ALL) 的数据.
- 开发和评估了一种基于生理学的全身药理动力学模型,用于重组L-asparaginase.
- 计算的种群药动力学参数,包括清除率,分布量,半衰期和最低度.
主要成果:
- 该PBPK模型准确地描述了儿科急性淋巴细胞白血病患者L-asparaginase的药理动力学.
- 计算的种群值:清除值 (0.0569 L/h/19.5 kg),分布体积 (1.251 L),半衰期 (18.5 h) 和最低度 (140.9 IU/L).
- 该模型的预测性能与人口药理动力学模型相比,预测的中位数低谷水平偏差为13%.
结论:
- 这项研究提出了第一个全身PBPK模型,用于非抗体治疗蛋白.
- PBPK建模为儿科瘤学中的药理动力学分析提供了准确且互补的方法.
- 开发的模型证明了PBPK在特定患者群体中表征药物倾向方面的潜力.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Physiological Models